RESUMO
Objective To detect fibrillin-1 gene (FBN1) mutations in patients with Marfan syndrome (MFS) by denaturing high-pedormance liquid chromatography (DHPLC) and DNA sequencing. Methods Genomic DNA was extracted from whole blood sample of 22 MFS patients. All 65 exens of FBN1 were amplified by polymerase chain reaction(PCR) respectively. Mutations were screened by DHPLC followed by DNA sequencing of the PCR products which showed different DHPLC profiles from the normals. Results Ten mutations of the FBN1 were found in 9 MFS patients. The mutations comprised four missense[5015G > C(C1672S),5309G > A(C1770Y),7241G > A(A2414G) and 7769G > A(C2590Y)], four nonsense [3295G > T ( E1099X ), 430"/insTCGT (G1441X), 4621C > T ( R1541X ) and 8080C > T (A2694X)], and two splice site mutations (IVS29 + 4A > T and IVSSO + 1G > A). Conclusion It is suggested that DHPLC coupled with DNA sequencing is an efficient method for the detection of FBN1 gene mutations, and it may be useful in diagnosis of MFS.
RESUMO
Objective To investigate the clinical research and effectiveness in double interventional therapy of middle or advanced stage hepatocellular carcinoma through liver arterial and portal vein. Methods Total of 86 patients of middle or advanced stage hepatocellular carcinoma divided into two groups. Group A double interventional therapy through liver arterial and portal vein chemotherapy and embolization 43 patients, Group B alone interventional therapy through liver arterial chemotherapy and embolization 43 patients.Results The Short-term effective rate was 86.1% and 69.8% in group A and group B, The Secondary operation rate was 16.2% and 4.7% in group A and group B, there was a significant difference between the two groups (P0.05). Conclusion The therapeutic effect of double interventional therapy through liver arterial and portal vein on middle or advanced stage hepatocellular carcinoma, is better than that of alone interventional therapy through liver arterial.
RESUMO
Design of low-cost, miniature, lightweight, ultra low-power, flexible sensor platform capable of customization and seamless integration into a wireless biomedical sensor network(WBSN) for health monitoring applications presents one of the most challenging tasks. In this paper, we propose a WBSN node platform featuring an ultra low-power microcontroller, an IEEE 802.15.4 compatible transceiver, and a flexible expansion connector. The proposed solution promises a cost-effective, flexible platform that allows easy customization, energy-efficient computation and communication. The development of a common platform for multiple physical sensors will increase reuse and alleviate costs of transition to a new generation of sensors. As a case study, we present an implementation of an ECG (Electrocardiogram) sensor.
RESUMO
Objective:To observe the effect of Kechuanning on Th cytokine expression in pediatric virus-induced asthma.Methods:120 cases of pediatric virus-induced asthma were randomly divided into Kechuanning group(treatment group,n =60,treated with Kechuanning) and Western medicine group(control group,n=60,treated with virazole).The change of Th1 cytokine IL-12 and Th2 cytokine IL-4 in blood serum were detected and analyzed.Results:Kechuanning could increase IL-12 but decrease IL-4 level in the patient's blood,therefore regulate Th cell subset,and the effect was more obvious than in control group.Conclusion:The mechanism of Kechuanning in curing pediatrics asthma induced by virus was related with increasing IL-12 and decreasing IL-4 level.
RESUMO
OBJECTIVE: To explore the nature of pathology of sluggishness of lung-defensive qi and to offer objective experimental indexes for weifen syndrome (defensive phase syndrome). METHODS: According to the completely random design, the plasma levels of vasoactive intestinal peptide (VIP) and thromboxane B2 (TX2) of 19 patients with weifen syndrome and 13 patients with qifen syndrome (qi phase syndrome) were detected by radioimmunoassay. The plasma levels of VIP and TX2 at different stages of weifen syndrome and qifen syndrome were observed. RESULTS: The plasma levels of VIP in weifen syndrome and in the late stage of weifen syndrome increased greatly at different stages as compared to qifen syndrome and the blank group (P 0.05). CONCLUSION: VIP may be an index reflecting the pathology of weifen syndrome, and it is one of the material foundations of sluggishness of lung-defensive qi, but it has nothing to do with the infected internal organs. The level of TX2 increases only after the fever of patients with weifen syndrome subsided, so it can not be the basis for diagnosis of the early stage of weifen syndrome. It doesn't increase in qifen syndrome either, the mechanism remains to be further studied.
